FINWIRES · TerminalLIVE
FINWIRES

Pharmaron Plans 5 Billion Yuan Investments in Drug Manufacturing Projects; Shares Slip 3%

By

Pharmaron Beijing (HKG:3759, SHE:300759) plans to invest a combined 5 billion yuan in drug manufacturing and CDMO projects in Zhejiang province, China, according to separate Wednesday filings with the Hong Kong bourse.

Hong Kong-listed shares of the pharmaceutical company were down nearly 3% in Thursday's midday trade.

The company plans to invest about 2 billion yuan in a new drug commercialization and CDMO production facility in Hangzhou's Qiantang district, with operations expected to begin in 2029.

Separately, Pharmaron plans to invest about 3 billion yuan in a Shaoxing project with an annual production capacity of 200 tonnes of pharmaceutical intermediates and active pharmaceutical ingredients, including products for obesity, diabetes, and oncology treatments.

The Shaoxing project's first phase is expected to begin operations in 2028, while the second phase is scheduled for 2030, subject to construction progress.

Related Articles

Asia

Chasen's Profit Slips in Fiscal H2; Shares Surge 11%

Chasen (SGX:5NV) booked a 1% decline in its profit in the fiscal second half ended March 31 of SG$6.4 million, from a profit of SG$6.5 million a year earlier, according to a Thursday filing with the Singapore Exchange.Earnings per share slid to SG$0.0168 from SG$0.0181 in the year-ago period.Revenue jumped 20% year over year to SG$67.8 million from SG$56.6 million.Shares of the global integrated logistics service provider zoomed over 11% in recent trade.

$SGX:5NV
Asia

Risecomm Group Enters Debt Swap Agreements With Creditors; Shares Jump 65%

Risecomm Group (HKG:1679) entered into an agreement with some creditors to issue a mix of debt and equity to settle outstanding loans, according to a Wednesday filing with the Hong Kong bourse.The power line communication products provider's shares gained 69% in late-morning trade Thursday.The firm will issue 69.8 million shares priced at HK$0.46 apiece and three-year convertible bonds worth HK$128.5 million to the creditors.The company simultaneously launched a public offering to raise funds to settle certain other loans.The firm is seeking investors for 85.9 million shares priced at HK$0.46 each, or HK$39.5 million in total, which will be used to repay loans owed to Fu Xiaoqin, a shareholder, and an entity identified as Clear Jolly.The transactions are subject to shareholder approval.

$HKG:1679
Asia

Aussie Broadband Makes International Mobile Roaming Available for Mobile Customers

Aussie Broadband (ASX:ABB) said international mobile roaming is now available for Aussie Broadband mobile customers under new updates being rolled out to the MyAussie and Carbon portals, according to a statement on Thursday.Customers will be able to access 5 gigabytes of data and unlimited calls and texts for AU$5 per day when travelling in Zone 1 countries without switching or acquiring a new SIM card or provider. For customers travelling in Zone 2 and Zone 3 countries, roaming prices will be charged at pay-as-you-go rates.Customers can also choose to opt out of international mobile roaming at any time, either directly through the app or by contacting Aussie Broadband's customer service.Its shares fell 1% in recent trading on Thursday.

$ASX:ABB